First human test for drug aiming to tame deadly 'Cytokine Storm' in lungs
Disease control
Not yet recruiting
This is a first-in-human safety study of an experimental drug called AVM0703 for patients with severe, life-threatening lung failure (ARDS) caused by COVID-19 or influenza. The study will enroll 16 critically ill patients who are on a ventilator or life support to test if a singl…
Phase: PHASE1 • Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC